These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 21386022

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. The first report of successful carotid stent implant using argatroban anticoagulation in a patient with heparin-induced thrombocytopenia and thrombosis syndrome: a case report.
    Lewis BE, Rangel Y, Fareed J.
    Angiology; 1998 Jan; 49(1):61-7. PubMed ID: 9456166
    [Abstract] [Full Text] [Related]

  • 44. Treatment of patients with a history of heparin-induced thrombocytopenia and anti-lepirudin antibodies with argatroban.
    Harenberg J, Jörg I, Fenyvesi T, Piazolo L.
    J Thromb Thrombolysis; 2005 Feb; 19(1):65-9. PubMed ID: 15976970
    [Abstract] [Full Text] [Related]

  • 45. Successful use of Argatroban as a heparin substitute during cardiopulmonary bypass: heparin-induced thrombocytopenia in a high-risk cardiac surgical patient.
    Edwards JT, Hamby JK, Worrall NK.
    Ann Thorac Surg; 2003 May; 75(5):1622-4. PubMed ID: 12735590
    [Abstract] [Full Text] [Related]

  • 46. Argatroban dosing of patients with heparin-induced thrombocytopenia and an elevated aPTT due to antiphospholipid antibody syndrome.
    Pendleton R, Wheeler MM, Rodgers GM.
    Ann Pharmacother; 2006 May; 40(5):972-6. PubMed ID: 16569813
    [Abstract] [Full Text] [Related]

  • 47. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia.
    Dang CH, Durkalski VL, Nappi JM.
    Pharmacotherapy; 2006 Apr; 26(4):461-8. PubMed ID: 16553503
    [Abstract] [Full Text] [Related]

  • 48. [Experimental and clinical results with the thrombin inhibitor Argatroban].
    Breddin HK.
    Hamostaseologie; 2002 Aug; 22(3):55-9. PubMed ID: 12215762
    [Abstract] [Full Text] [Related]

  • 49. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia.
    Lewis BE, Wallis DE, Leya F, Hursting MJ, Kelton JG, Argatroban-915 Investigators.
    Arch Intern Med; 2002 Aug; 163(15):1849-56. PubMed ID: 12912723
    [Abstract] [Full Text] [Related]

  • 50. Recognition of heparin-induced thrombocytopenia and initiation of argatroban therapy after cardiothoracic surgery in the intensive care unit.
    Demma LJ, Paciullo CA, Levy JH.
    J Thorac Cardiovasc Surg; 2012 May; 143(5):1213-8. PubMed ID: 22329977
    [Abstract] [Full Text] [Related]

  • 51. Argatroban therapy in women with heparin-induced thrombocytopenia.
    Jang IK, Baron SJ, Hursting MJ, Anglade E.
    J Womens Health (Larchmt); 2007 May; 16(6):895-901. PubMed ID: 17678460
    [Abstract] [Full Text] [Related]

  • 52. Argatroban anticoagulation for cardiac surgery with cardiopulmonary bypass in an infant with double outlet right ventricle and a history of heparin-induced thrombocytopenia.
    Ciccolo ML, Bernstein J, Collazos JC, Acherman RJ, Restrepo H, Winters JM, Krueger J, Evans WN.
    Congenit Heart Dis; 2008 May; 3(4):299-302. PubMed ID: 18715467
    [Abstract] [Full Text] [Related]

  • 53. [Heparin-induced thrombocytopenia (HIT): pathogenesis, laboratory test, and treatment].
    Matsuo T, Wanaka K, Asada R.
    Rinsho Byori; 2005 Jul; 53(7):622-9. PubMed ID: 16104531
    [Abstract] [Full Text] [Related]

  • 54. [Anticoagulant efficacy and safety of argatroban for patients undergoing elective percutaneous coronary intervention].
    Tian F, Yu H, Chen YD, Liu HB, Guo J, Sun ZJ, Jin QH, Yan F, Ma YL, Gu XF.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Jun; 41(6):480-3. PubMed ID: 24113039
    [Abstract] [Full Text] [Related]

  • 55. Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin-induced thrombocytopenia.
    Kiser TH, Jung R, MacLaren R, Fish DN.
    Pharmacotherapy; 2005 Dec; 25(12):1736-45. PubMed ID: 16305293
    [Abstract] [Full Text] [Related]

  • 56. Argatroban usage for anticoagulation for ECMO on a post-cardiac patient with heparin-induced thrombocytopenia.
    Mejak B, Giacomuzzi C, Heller E, You X, Ungerleider R, Shen I, Boshkov L.
    J Extra Corpor Technol; 2004 Jun; 36(2):178-81. PubMed ID: 15334762
    [Abstract] [Full Text] [Related]

  • 57. [Open heart surgery using cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia(HIT)].
    Furukawa H, Konishi T, Fukata M, Okada H, Sakagami N, Kurosaki K.
    Kyobu Geka; 2013 May; 66(5):383-6. PubMed ID: 23674036
    [Abstract] [Full Text] [Related]

  • 58. Heparin-induced thrombocytopenia in intensive care patients.
    Selleng K, Warkentin TE, Greinacher A.
    Crit Care Med; 2007 Apr; 35(4):1165-76. PubMed ID: 17334253
    [Abstract] [Full Text] [Related]

  • 59. Argatroban in the management of heparin-induced thrombocytopenia: a multicenter clinical trial.
    Tardy-Poncet B, Nguyen P, Thiranos JC, Morange PE, Biron-Andréani C, Gruel Y, Morel J, Wynckel A, Grunebaum L, Villacorta-Torres J, Grosjean S, de Maistre E.
    Crit Care; 2015 Nov 11; 19():396. PubMed ID: 26556106
    [Abstract] [Full Text] [Related]

  • 60. Argatroban dosing in patients with heparin-induced thrombocytopenia.
    Verme-Gibboney CN, Hursting MJ.
    Ann Pharmacother; 2003 Nov 11; 37(7-8):970-5. PubMed ID: 12841802
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.